Impact of the hepatopulmonary syndrome MELD exception policy on outcomes of patients after liver transplantation: An analysis of the UNOS database

Gastroenterology

Volumn 146, Issue 5, 2014, Pages

  Goldberg, David S ^a,b   Krok, Karen ^c   Batra, Sachin ^d   Trotter, James F ^e   Kawut, Steven M ^b   Fallon, Michael B ^d  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^d UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^e BAYLOR UNIVERSITY   (United States)

Author keywords

Allocation; Gas Exchange; Keywords; MELD; UNOS

Indexed keywords

ADULT; AMBIENT AIR; ARTICLE; COHORT ANALYSIS; DECOMPENSATED LIVER CIRRHOSIS; END STAGE LIVER DISEASE; FEMALE; FOLLOW UP; GRAFT RECIPIENT; HEALTH CARE POLICY; HEPATOPULMONARY SYNDROME; HOSPITAL ADMISSION; HUMAN; LIVER GRAFT; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; OXYGENATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURGICAL PATIENT;

ALLOCATION; GAS EXCHANGE; MELD; UNOS;

ANOXIA; DATABASES, FACTUAL; FEMALE; HEPATOPULMONARY SYNDROME; HUMANS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; OXYGEN INHALATION THERAPY; PATIENT SELECTION; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TISSUE AND ORGAN PROCUREMENT; TREATMENT OUTCOME; UNITED STATES; WAITING LISTS;

EID: 84899446329     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2014.01.005     Document Type: Article

References (42)

1. M.J. Krowka, G.A. Wiseman, and O.L. Burnett et al. Hepatopulmonary syndrome: a prospective study of relationships between severity of liver disease, PaO(2) response to 100% oxygen, and brain uptake after (99m)Tc MAA lung scanning Chest 118 2000 615 624
2. K.L. Swanson, R.H. Wiesner, and M.J. Krowka Natural history of hepatopulmonary syndrome: Impact of liver transplantation Hepatology 41 2005 1122 1129
3. M.J. Krowka, and M.B. Fallon Liver transplantation for hepatopulmonary syndrome (HPS): what is the MESSAGE? Am J Transplant 8 2008 911 912
4. M.J. Krowka, M.S. Mandell, and M.A. Ramsay et al. Hepatopulmonary syndrome and portopulmonary hypertension: a report of the multicenter liver transplant database Liver Transpl 10 2004 174 182
5. M.B. Fallon, M.J. Krowka, and R.S. Brown et al. Impact of hepatopulmonary syndrome on quality of life and survival in liver transplant candidates Gastroenterology 135 2008 1168 1175
6. P.S. Kamath, R.H. Wiesner, and M. Malinchoc et al. A model to predict survival in patients with end-stage liver disease Hepatology 33 2001 464 470
7. R. Wiesner, E. Edwards, and R. Freeman et al. Model for end-stage liver disease (MELD) and allocation of donor livers Gastroenterology 124 2003 91 96
8. M.R. Arguedas, G.A. Abrams, M.J. Krowka, and M.B. Fallon Prospective evaluation of outcomes and predictors of mortality in patients with hepatopulmonary syndrome undergoing liver transplantation Hepatology 37 2003 192 197
9. B.M. Sulieman, L.G. Hunsicker, D.A. Katz, and M.D. Voigt OPTN policy regarding prioritization of patients with hepatopulmonary syndrome: does it provide equitable organ allocation? Am J Transplant 8 2008 954 964
10. S. Gupta, H. Castel, and R.V. Rao et al. Improved survival after liver transplantation in patients with hepatopulmonary syndrome Am J Transplant 10 2010 354 363
11. V.N. Iyer, K.L. Swanson, and R. Cartin-Ceba et al. Hepatopulmonary syndrome: favorable outcomes in the MELD exception era Hepatology 57 2013 2427 2435
12. G.A. Abrams, N.C. Nanda, and E.V. Dubovsky et al. Use of macroaggregated albumin lung perfusion scan to diagnose hepatopulmonary syndrome: a new approach Gastroenterology 114 1998 305 310
13. M.M. Hoeper, M.J. Krowka, and C.P. Strassburg Portopulmonary hypertension and hepatopulmonary syndrome Lancet 363 9419 2004 1461 1468
14. M.B. Fallon, D.C. Mulligan, R.G. Gish, and M.J. Krowka Model for end-stage liver disease (MELD) exception for hepatopulmonary syndrome Liver Transpl 12 Suppl 3 2006 S105 S107
15. M.R. Arguedas, H. Singh, D.K. Faulk, and M.B. Fallon Utility of pulse oximetry screening for hepatopulmonary syndrome Clin Gastroenterol Hepatol 5 2007 749 754
16. D. Goldberg, B. French, and P. Abt et al. Increasing disparity in waitlist mortality rates with increased model for end-stage liver disease scores for candidates with hepatocellular carcinoma versus candidates without hepatocellular carcinoma Liver Transpl 18 2012 434 443
17. C.A. Moylan, C.W. Brady, and J.L. Johnson et al. Disparities in liver transplantation before and after introduction of the MELD score JAMA 300 2008 2371 2378
18. W.R. Kim, T.M. Therneau, and J.T. Benson et al. Deaths on the liver transplant waiting list: an analysis of competing risks Hepatology 43 2006 345 351
19. J.M. Satagopan, L. Ben-Porat, and M. Berwick et al. A note on competing risks in survival data analysis Br J Cancer 91 2004 1229 1235
20. J.P. Fine, and R.J. Gray A proportional hazards model for the subdistribution of a competing risk J Am Stat Assoc 94 446 1999 496 509
21. F.J. Roughton, and J.W. Severinghaus Accurate determination of O2 dissociation curve of human blood above 98.7 percent saturation with data on O2 solubility in unmodified human blood from 0 degrees to 37 degrees C J Appl Physiol 35 1973 861 869
22. Cornell University. Oxygen saturation, calculated. Available at: http://www-users.med.cornell.edu/∼spon/picu/calc/o2satcal.htm. Accessed July 13, 2013.
23. G.A. Abrams, M.K. Sanders, and M.B. Fallon Utility of pulse oximetry in the detection of arterial hypoxemia in liver transplant candidates Liver Transpl 8 2002 391 396
24. B. French, and P.J. Heagerty Analysis of longitudinal data to evaluate a policy change Stat Med 27 2008 5005 5025
25. R.B. Freeman Jr., R.G. Gish, and A. Harper et al. Model for end-stage liver disease (MELD) exception guidelines: results and recommendations from the MELD Exception Study Group and Conference (MESSAGE) for the approval of patients who need liver transplantation with diseases not considered by the standard MELD formula Liver Transpl 12 Suppl 3 2006 S128 S136
26. S. Feng, N.P. Goodrich, and J.L. Bragg-Gresham et al. Characteristics associated with liver graft failure: the concept of a donor risk index Am J Transplant 6 2006 783 790
27. P. Schenk, M. Schoniger-Hekele, and V. Fuhrmann et al. Prognostic significance of the hepatopulmonary syndrome in patients with cirrhosis Gastroenterology 125 2003 1042 1052
28. N. Molinari, J.P. Daures, and J.F. Durand Regression splines for threshold selection in survival data analysis Stat Med 20 2001 237 247
29. F.E. Harrell Jr., K.L. Lee, and B.G. Pollock Regression models in clinical studies: determining relationships between predictors and response J Natl Cancer Inst 80 1988 1198 1202
30. Y. Tsugawa, K.J. Mukamal, and R.B. Davis et al. Should the hemoglobin A(1c) diagnostic cutoff differ between blacks and whites? A cross-sectional study Ann Intern Med 157 2012 153 159
31. R.C. Bailey, M. Jia-Yeong Lin, and H. Krakauer Time-to-event modeling of competing risks with intervening states in transplantation Am J Transplant 3 2003 192 202
32. H. Putter, M. Fiocco, and R.B. Geskus Tutorial in biostatistics: competing risks and multi-state models Stat Med 26 2007 2389 2430
33. D. Posada, and T.R. Buckley Model selection and model averaging in phylogenetics: advantages of akaike information criterion and bayesian approaches over likelihood ratio tests Syst Biol 53 2004 793 808
34. M. Somsouk, R. Kornfield, and E. Vittinghoff et al. Moderate ascites identifies patients with low model for end-stage liver disease scores awaiting liver transplantation who have a high mortality risk Liver Transpl 17 2011 129 136
35. J.G. O'Leary, R. Lepe, and G.L. Davis Indications for liver transplantation Gastroenterology 134 2008 1764 1776
36. R.M. Merion, D.E. Schaubel, and D.M. Dykstra et al. The survival benefit of liver transplantation Am J Transplant 5 2005 307 313
37. D.E. Schaubel, M.K. Guidinger, and S.W. Biggins et al. Survival benefit-based deceased-donor liver allocation Am J Transplant 9 Pt 2 2009 970 981
38. V. Mazzaferro, E. Regalia, and R. Doci et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis N Engl J Med 334 1996 693 699
39. J. Bruix, and M. Sherman Management of hepatocellular carcinoma: an update Hepatology 53 2011 1020 1022
40. M.L. Volk, S. Vijan, and J.A. Marrero A novel model measuring the harm of transplanting hepatocellular carcinoma exceeding Milan criteria Am J Transplant 8 2008 839 846
41. OPTN/UNOS policies and bylaws. Available at: http://optn.transplant.hrsa. gov/PoliciesandBylaws2/policies/pdfs/policy-8.pdf. Accessed September 2, 2013.
42. J.S. Fritz, M.B. Fallon, and S.M. Kawut Pulmonary vascular complications of liver disease Am J Respir Crit Care Med 187 2013 133 143